MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

Store in well-closed containers.

Provenance

This compatibility recommendation is derived from Allopurinol 300mg tablets (Accord Healthcare Ltd) and Zyloric 300mg tablets (Aspen Pharma Trading Ltd).

Stability Notes

Store in well-closed containers.

Provenance

This compatibility recommendation is derived from Allopurinol 300mg tablets (Accord Healthcare Ltd) and Zyloric 300mg tablets (Aspen Pharma Trading Ltd).

Stability Notes

Hygroscopic. Protect from light and moisture. Can cause contact dermatitis, wear gloves if handling tablets. May discolour. Max 28 days in MCA.

Provenance

Compatibility recommendation derived from Eli Lilly and Accord Pharmaceuticals Ltd products.

Stability Notes

Hygroscopic. Protect from light and moisture. Can cause contact dermatitis, wear gloves if handling tablets. May discolour. Max 28 days in MCA.

Provenance

Compatibility recommendation derived from Eli Lilly and Accord Pharmaceuticals Ltd products.

Stability Notes

Hygroscopic. Protect from light and moisture. Can cause contact dermatitis, wear gloves if handling tablets. May discolour. Max 28 days in MCA.

Provenance

Compatibility recommendation derived from Eli Lilly and Accord Pharmaceuticals Ltd products.

Stability Notes

Hygroscopic. Protect from light and moisture. Can cause contact dermatitis, wear gloves if handling tablets. May discolour. Max 28 days in MCA.

Provenance

Compatibility recommendation derived from Eli Lilly and Accord Pharmaceuticals Ltd products.

Stability Notes

Hygroscopic. Protect from light and moisture. Can cause contact dermatitis, wear gloves if handling tablets. May discolour. Max 28 days in MCA.

Provenance

Compatibility recommendation derived from Eli Lilly and Accord Pharmaceuticals Ltd products.

Stability Notes

Do not open until immediately prior to use. May disintegrate in moisture in the air.

Provenance

Compatibility information derived from Zyprexa 10mg Velotabs (Eli Lilly and Company Ltd).

Stability Notes

Do not open until immediately prior to use. May disintegrate in moisture in the air.

Provenance

Compatibility information derived from Zyprexa 10mg Velotabs (Eli Lilly and Company Ltd).

Stability Notes

Do not open until immediately prior to use. May disintegrate in moisture in the air.

Provenance

Compatibility information derived from Zyprexa 10mg Velotabs (Eli Lilly and Company Ltd).

Stability Notes

Hygroscopic. Protect from light and moisture. Can cause contact dermatitis, wear gloves if handling tablets. May discolour. Max 28 days in MCA.

Provenance

Compatibility recommendation derived from Eli Lilly and Accord Pharmaceuticals Ltd products.

Stability Notes

Hygroscopic. Protect from light and moisture. Can cause contact dermatitis, wear gloves if handling tablets. May discolour. Max 28 days in MCA.

Provenance

Compatibility recommendation derived from Eli Lilly and Accord Pharmaceuticals Ltd products.

Stability Notes

Do not open until immediately prior to use. May disintegrate in moisture in the air.

Provenance

Compatibility recommendation derived from Zyprexa 15mg Velotabs (Eli Lilly and Company Ltd).

Stability Notes

Do not open until immediately prior to use. May disintegrate in moisture in the air.

Provenance

Compatibility recommendation derived from Zyprexa 15mg Velotabs (Eli Lilly and Company Ltd).

Stability Notes

Hygroscopic. Protect from light and moisture. Can cause contact dermatitis, wear gloves if handling tablets. May discolour. Max 28 days in MCA.

Provenance

Compatiblity recommendation derived from Eli Lilly and Accord Healthcare Ltd products.

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.